Welcome to Nutraceuticals World   
October 2014 Issue
Last Updated Wednesday, October 22 2014
Print

Nestlé Invests in Space Between Food & Pharma



Published September 27, 2010
Related Searches: Research Nutrition Obesity Healthcare
In an effort to pioneer a new industry between food and pharma, Nestlé has created Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences. These two separate organizations will allow Nestlé to develop the innovative area of personalized health science nutrition to prevent and treat health conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s disease, which are placing an unsustainable burden on the world’s healthcare systems.

Nestlé Health Science S.A., a wholly-owned subsidiary of Nestlé S.A., will become operational on 1 January 2011. The new company will be run at arm’s length from Nestlé’s main food, beverages and nutrition activities, and incorporate the existing global Nestlé HealthCare Nutrition business, which had a turnover of CHF 1.6 billion in 2009. Nestlé Health Science S.A. will also have access to external scientific and technological know-how through Nestlé’s innovation network as well as a number of venture capital funds in which the group has interests.

Luis Cantarell, the company’s designated president and CEO, will report to Paul Bulcke in his capacity as administrateur délégué of the Board of Directors of Nestlé Health Science S.A., which is chaired by Peter Brabeck-Letmathe.

The Nestlé Institute of Health Sciences will be part of Nestlé’s global R&D network. Nestlé will invest hundreds of millions of Swiss francs over the next decade to build a world-class Institute of Health Sciences, which will conduct research in relevant areas of biomedical science to translate this knowledge into nutritional strategies to improve health and longevity. The institute will be based in the multi-disciplinary scientific environment of the Swiss Federal Institute of Technology (EPFL) in Lausanne, where Nestlé is already involved in two life science initiatives.

Nestlé Chairman Peter Brabeck-Letmathe said that Nestlé will be a pioneer in helping to shape the space between the food and pharma industry. “The combination of health economics, changing demographics and advances in health science show that our existing healthcare systems, which focus on treating sick people, are not sustainable and need redesigning. Nestlé has the expertise, the science, the resources and the organization to play a major role in seeking alternative solutions. Personalized health science nutrition is about finding efficient and cost effective ways to prevent and treat acute and chronic diseases in the 21st century,” he said.

Nestlé CEO Paul Bulcke said: “The creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences is the best way to focus our attention and organize our unique capabilities and competencies to seize this promising business opportunity. The new set-up will give us a pioneering and leading role in this entirely new industry, while at the same time allowing us to keep the necessary focus on Nestlé’s extremely important food, beverages and nutrition business, as embodied by our binding promise of ‘Good Food, Good Life.’”


Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On